Drugs / 3APS
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00217763 | Sep 2005 → Dec 2007 | Alzheimer disease | Bellus Health Inc. - a GSK company | Unknown | No outcome recorded |
| Phase 3 | NCT00088673 | Jun 2004 → ? | Alzheimer disease | Bellus Health Inc. - a GSK company | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 3APS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00088673 ↗ |